» Articles » PMID: 32995359

Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct

Abstract

Stable suspension producer cell lines for the production of vesicular stomatitis virus envelope glycoprotein (VSVg)-pseudotyped lentiviral vectors represent an attractive alternative to current widely used production methods based on transient transfection of adherent 293T cells with multiple plasmids. We report here a method to rapidly generate such producer cell lines from 293T cells by stable transfection of a single DNA construct encoding all lentiviral vector components. The resulting suspension cell lines yield titers as high as can be achieved with transient transfection, can be readily scaled up in single-use stirred-tank bioreactors, and are genetically and functionally stable in extended cell culture. By removing the requirement for efficient transient transfection during upstream processing of lentiviral vectors and switching to an inherently scalable suspension cell culture format, we believe that this approach will result in significantly higher batch yields than are possible with current manufacturing processes and enable better patient access to medicines based on lentiviral vectors.

Citing Articles

Cell-based assay to detect small molecules restoring levels of let-7 miRNAs.

Szewczyk S, Buckley B, Chernov M, Wang X, Pathak S, Yeger H Am J Cancer Res. 2024; 14(10):4772-4787.

PMID: 39553217 PMC: 11560832. DOI: 10.62347/MBLD9480.


Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors.

Arrasate A, Bravo I, Lopez-Robles C, Arbelaiz-Sarasola A, Ugalde M, Meijueiro M Biomedicines. 2024; 12(10).

PMID: 39457578 PMC: 11504443. DOI: 10.3390/biomedicines12102265.


Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process.

Tridgett M, Mulet M, Johny S, Ababi M, Raghunath M, Fustinoni C Mol Ther Methods Clin Dev. 2024; 32(3):101315.

PMID: 39282073 PMC: 11401174. DOI: 10.1016/j.omtm.2024.101315.


Promises and challenges of a decentralized CAR T-cell manufacturing model.

Shah M, Krull A, ODonnell L, De Lima M, Bezerra E Front Transplant. 2024; 2:1238535.

PMID: 38993860 PMC: 11235344. DOI: 10.3389/frtra.2023.1238535.


Effects of an indole derivative on cell proliferation, transfection, and alternative splicing in production of lentiviral vectors by transient co-transfection.

Mier N, Roper D PLoS One. 2024; 19(6):e0297817.

PMID: 38833479 PMC: 11149887. DOI: 10.1371/journal.pone.0297817.


References
1.
OConnor M, Peifer M, Bender W . Construction of large DNA segments in Escherichia coli. Science. 1989; 244(4910):1307-12. DOI: 10.1126/science.2660262. View

2.
Moriarity B, Rahrmann E, Keng V, Manlove L, Beckmann D, Wolf N . Modular assembly of transposon integratable multigene vectors using RecWay assembly. Nucleic Acids Res. 2013; 41(8):e92. PMC: 3632113. DOI: 10.1093/nar/gkt115. View

3.
Vogt B, Roscher S, Abel B, Hildinger M, Lamarre A, Baum C . Lack of superinfection interference in retroviral vector producer cells. Hum Gene Ther. 2001; 12(4):359-65. DOI: 10.1089/10430340150503984. View

4.
McCarron A, Donnelley M, McIntyre C, Parsons D . Challenges of up-scaling lentivirus production and processing. J Biotechnol. 2016; 240:23-30. DOI: 10.1016/j.jbiotec.2016.10.016. View

5.
Dull T, Zufferey R, Kelly M, Mandel R, Nguyen M, Trono D . A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998; 72(11):8463-71. PMC: 110254. DOI: 10.1128/JVI.72.11.8463-8471.1998. View